Paul Geyer

Clarius’ mission is to make accurate, easy-to-use and affordable ultrasound tools available to all medical professionals. Its handheld wireless ultrasound scanners connect to iOS and Android devices, delivering high resolution ultrasound images traditionally only available with bulkier, high end systems. More than half a million scans have been performed by 20,000 users since Clarius introduced its first portable scanner in 2016. Clarius scanners are available in more than 50 countries, with the new Clarius HD available now in Canada, the United States and Europe, other countries to follow.

Sonic Incytes is committed to enhancing patient care through innovative diagnostic solutions. The companys flagship product, Velacur™, equips physicians with an advanced liver imaging tool to help manage the growing epidemic of fatty liver disease. Velacur offers real-time, AI guided quantification of the two key markers for fatty liver disease: liver stiffness and attenuation. With real-time results, a low up-front cost and AI guidance, VELACUR makes liver imaging at the point of care affordable and accessible.

Building & Managing Market-Leading Private Credit Opportunities

Since 2012, Claris Healthcare has been enabling patients to manage their own care at home. Our care platform is used across the remote care continuum including social, chronic, and rehabilitation. Our Remote Patient Monitoring (Claris Continuum), Social Isolation (Claris Companion) and Acute Rehabilitation (Claris reflex) configurations require no on-site installation, setup or training - they work right out of the box. Providers use Claris Continuum to engage and monitor patients with chronic diseases such as heart disease, diabetes, COPD, etc. The sophisticated caregiver portal simplifies recording of activities for RPM billings, helping to maximize revenues. Family members use Claris Companion to communicate with and monitor their aging loved-ones remotely. Companion is designed to be accessible to even the most techno-phobic users and can be deployed into the homes of seniors without the need for installation, setup or training. Providers use Claris Reflex to guide patients through rehabilitation after acute interventions - providing timely advice and coaching in the home using customized Care Programs. Patients report better overall satisfaction due to simpler communication with care providers, access to instructional videos and information, as well as direct feedback on their recovery performance. The Claris platform offers a wide range of deployment options - from fully integrated kits provided by Claris through 'bring your own device' for those who have their own smart phones or tablets, through 'direct to cloud' vital signs devices that require no mobile device in the home at all. Providers can choose any mixture of device options for their patients, all reporting back to one common care portal. The Claris platform is all about flexibility, configurability, accessibility and engagement. No other home care delivery platform provides such a wide range of options in one product.

Starling Minds™ is a leading scientifically-based mental health platform for organizations looking to take a proactive approach to support mental well-being in the workplace. Our powerful digital platform provides the knowledge, tools, and techniques to support, empathize with and rehabilitate workers who are coping with stress, anxiety, and depression when they need it most — any time, any place. Organizations who choose Starling Minds™ receive responsive support, periodic reports, and a customized success plan to facilitate a healthier, happier workplace. People who use Starling Minds™ are more resilient and better equipped in the face of adversity, resulting in more confident leadership, stronger teams, and greater productivity. We are Starling Minds. Mentally Resilient People. Happier, Healthier & More Productive Workplaces.

ALAViDA Substance Use, a product of LifeSpeak Inc., is an unparalleled and evidence-based solution for members looking to make changes toward a healthier lifestyle. Our solution is full of resources and personalized therapeutic services, our solution provides a safe and discreet atmosphere for members. ALAViDA Substance Use is an employee benefit with varying plans and personalized therapeutic programs, which has proven to minimize time out of the workplace. More than 79 percent of those signed on reported increased control, 86 percent reduced substance use, and 95 percent remained on the job while undergoing treatment. To learn more, please visit our website.

Eupraxia is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to currently approved drugs. Each of Eupraxia's product candidates has the potential to address therapeutic areas with high unmet medical need, and strives to provide improved patient benefit by delivering targeted, long-lasting activity with fewer side effects. In addition to Eupraxia’s lead product candidate, EP-104IAR, Eupraxia is developing a pipeline of earlier-stage long-acting formulations. Potential pipeline candidates include a range of drugs for indications such as post-surgical pain (EP-105), and post-surgical site infections (EP-201), each designed to improve on the activity and tolerability of approved drugs. Eupraxia is also developing a formulation of EP-104IAR for use in canine and equine osteoarthritis.

Clarius’ mission is to make accurate, easy-to-use and affordable ultrasound tools available to all medical professionals. Its handheld wireless ultrasound scanners connect to iOS and Android devices, delivering high resolution ultrasound images traditionally only available with bulkier, high end systems. More than half a million scans have been performed by 20,000 users since Clarius introduced its first portable scanner in 2016. Clarius scanners are available in more than 50 countries, with the new Clarius HD available now in Canada, the United States and Europe, other countries to follow.

Sonic Incytes is committed to enhancing patient care through innovative diagnostic solutions. The companys flagship product, Velacur™, equips physicians with an advanced liver imaging tool to help manage the growing epidemic of fatty liver disease. Velacur offers real-time, AI guided quantification of the two key markers for fatty liver disease: liver stiffness and attenuation. With real-time results, a low up-front cost and AI guidance, VELACUR makes liver imaging at the point of care affordable and accessible.

Building & Managing Market-Leading Private Credit Opportunities

Neovasc is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products include the Neovasc Reducer™ for the treatment of refractory angina and the Tiara™ technology in development for the transcatheter treatment of mitral valve disease. To receive Neovasc updates via email, please register at: http://www.neovasc.com/register.

Since 2012, Claris Healthcare has been enabling patients to manage their own care at home. Our care platform is used across the remote care continuum including social, chronic, and rehabilitation. Our Remote Patient Monitoring (Claris Continuum), Social Isolation (Claris Companion) and Acute Rehabilitation (Claris reflex) configurations require no on-site installation, setup or training - they work right out of the box. Providers use Claris Continuum to engage and monitor patients with chronic diseases such as heart disease, diabetes, COPD, etc. The sophisticated caregiver portal simplifies recording of activities for RPM billings, helping to maximize revenues. Family members use Claris Companion to communicate with and monitor their aging loved-ones remotely. Companion is designed to be accessible to even the most techno-phobic users and can be deployed into the homes of seniors without the need for installation, setup or training. Providers use Claris Reflex to guide patients through rehabilitation after acute interventions - providing timely advice and coaching in the home using customized Care Programs. Patients report better overall satisfaction due to simpler communication with care providers, access to instructional videos and information, as well as direct feedback on their recovery performance. The Claris platform offers a wide range of deployment options - from fully integrated kits provided by Claris through 'bring your own device' for those who have their own smart phones or tablets, through 'direct to cloud' vital signs devices that require no mobile device in the home at all. Providers can choose any mixture of device options for their patients, all reporting back to one common care portal. The Claris platform is all about flexibility, configurability, accessibility and engagement. No other home care delivery platform provides such a wide range of options in one product.